feed,title,long_url,short_url
Benzinga,"Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy Questions",https://benzinga.com/general/biotech/21/07/21962513/ahead-of-adcomm-astrazeneca-fibrogens-roxadustat-hit-with-safety-efficacy-questions,https://j.mp/36uKzIW
